北海道医療大学がん予防研究所の業績

和文誌

  1. 浅香正博、赤澤祐子:がん研究機関(IARC)から発表された "Helicobacter pylori 除菌による胃がん予防戦略" 報告書の解説、Helicobacter Res 19:69-82,2015
  2. 浅香正博:巻頭言、Helicobacter日本語抄訳版 19:2-3,2015
  3. 浅香正博:WHOのIARCから発表された "H. pylori 除菌による胃がん予防戦略、2014" の解説、日本ヘリコバクター学会誌 17:19-20,2015
  4. 浅香正博、寺野 彰:対談;消化器病医が知っておかねばならない法律知識、GI Forefront 11:89-95,2015.

英文誌

  1. Sugano K, Tack J, Kuipers EJ, Graham DY, El-Omar EM, Miura S, Haruma K, Asaka M, Uemura N, Malfertheiner P. Kyoto global consensuss report on Helicobacter pylori gastritis. GUT 64:1353-1367,2015
  2. Asaka M, Mabe K, Matsushima R, Tsuda M. Helicobacter pylori Eradication to Eliminate Gastric Cancer: The Japanese Strategy. Gastroenterol Clin North Am. 44:639-48, 2015
  3. Nakagawa K, Kohara T, Uehata Y, Miyakawa Y, Sato-Ueshima M, Okubo N Asaka M, Takeda H, Kobayashi M. PIAS3 enhances the transcriptional activity of HIF-1α by increasing its protein stability. Biochem Biophys Res Commun. 2016 : 469:470-6.
  4. Fujitsuka N, Asakawa A, Morinaga A, Amitani MS, Amitani H, Katsuura G, Sawada Y, Sudo Y, Uezono Y, Mochiki E, Sakata I, Sakai T, Hanazaki K, Yada T, Yakabi K, Sakuma E, Ueki T, Niijima A, Nakagawa K, Okubo N, Takeda H, Asaka M, Inui A. Increased ghrelin signaling prolongs survival in mouse models of human aging through activation of sirtuin1. Mol Psychiatry. 2016 Feb 2.
  5. Morita R, Hirohashi Y, Torigoe T, Ito-Inoda S, Takahashi A, Mariya T, Asanuma H, Tamura Y, Tsukahara T, Kanaseki T, Kubo T, Kutomi G, Mizuguchi T, Terui T, Ishitani K, Hashino S, Kondo T, Minagawa N, Takahashi N, Taketomi A, Todo S, Asaka M, Sato N. Olfactory Receptor Family 7 Subfamily C Member 1 Is a Novel Marker of Colon Cancer-Initiating Cells and Is a Potent Target of Immunotherapy. Clin Cancer Res. 2016 Feb 9.
  6. Murakami K, Sakurai Y, Shiino M, Funao N, Nishimura A, Asaka M. Vonoprazan, a novel potassium-competitive acid blocker, as a component of first-line and second-line triple therapy for Helicobacter pylori eradication: a phase III, randomised, double-blind study. Gut. 2016 Mar 2
  7. Yamada T, Horimoto H, Kameyama T, Hayakawa S, Yamato H, Dazai M, Takada A, Kida H, Bott D, Zhou AC, Hutin D, Watts TH, Asaka M, Matthews J, Takaoka A. Constitutive aryl hydrocarbon receptor signaling constrains type I interferon-mediated antiviral innate defense. Nat Immunol. 2016 Apr 18.

国際学会

  1. Special lecture: Roadmap to eliminate gastric cancer in Japan. 2015.9 15th Congress of Gastroenterology China 2015. Tianjin, China

国内学会

  1. 浅香正博:腫瘍別シンポジウム“胃がん:基礎・臨床研究の最前線;わが国から胃がんを撲滅する具体的戦略”、第74回日本癌学会総会、名古屋、2015,10
  2. 浅香正博:特別講演“わが国の胃がん関連死を2020年までに50%減少させるための戦略”、第90回日本消化器内視鏡学会総会、東京、2015、10
  3. 浅香正博:分野別シンポジウム“胃がん予防のための中学生ピロリ菌検診と除菌はどうあるべきか”、わが国の胃がん撲滅戦略の概要、第119回日本小児科学会学術集会、札幌、2016,5